The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review
Open Access
- 18 May 2022
- journal article
- review article
- Published by Elsevier in Clinical Medicine
- Vol. 22 (3) , 257-265
Abstract
Background Evidence and guidelines increasingly support an individualised approach to care for people with type 2 diabetes and individualisation of glycaemic targets in response to patient factors. Methods We undertook a scoping review of the literature for evidence of factors impacting upon glycated haemoglobin target individualisation in adults with type 2 diabetes. Data were analysed thematically with the themes inductively derived from article review. Findings Evidence suggests that presence of cardiovascular disease, hypoglycaemia unawareness, severe hypoglycaemia, limited life expectancy, advanced age, long diabetes duration, frailty, cognitive impairment, disability, extensive comorbidity, diabetes distress and patient preference should inform the setting of glycaemic targets. Conclusion The management of people with diabetes is complex. In clinical practice, many patients will have a variety of factors that should be considered when personalising their care. Approaches to personalised care and glycaemic treatment targets should be undertaken as part of a shared decision-making process between physician and patient. Use of electronic records might enable greater efficiency and more widespread use of personalised care plans for people with diabetes.Keywords
This publication has 66 references indexed in Scilit:
- Poor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 DiabetesDiabetes Care, 2012
- Glycemic Control, Complications, and Death in Older Diabetic PatientsDiabetes Care, 2011
- Association of Diabetes, Comorbidities, and A1C With Functional Disability in Older AdultsDiabetes Care, 2010
- Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes MellitusJAMA, 2009
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Perceptions of Quality‐of‐Life Effects of Treatments for Diabetes Mellitus in Vulnerable and Nonvulnerable Older PatientsJournal of the American Geriatrics Society, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Variation in Treatment Preferences and Care Goals Among Older Patients With Diabetes and Their PhysiciansMedical Care, 2008